Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Protagonist Therapeutics (PTGX) Debt Ratio (2018 - 2023)

Protagonist Therapeutics (PTGX) has disclosed Debt Ratio for 6 consecutive years, with 0.0 as the latest value for Q2 2023.

  • Quarterly Debt Ratio fell 87.89% to 0.0 in Q2 2023 from the year-ago period, while the trailing twelve-month figure was 0.0 through Jun 2023, down 87.89% year-over-year, with the annual reading at 0.0 for FY2022, 89.24% down from the prior year.
  • Debt Ratio hit 0.0 in Q2 2023 for Protagonist Therapeutics, down from 0.0 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.03 in Q2 2021 to a low of 0.0 in Q2 2023.
  • Historically, Debt Ratio has averaged 0.01 across 5 years, with a median of 0.0 in 2019.
  • Biggest five-year swings in Debt Ratio: soared 532.36% in 2021 and later plummeted 99.09% in 2022.
  • Year by year, Debt Ratio stood at 0.01 in 2019, then rose by 3.36% to 0.01 in 2020, then tumbled by 69.29% to 0.0 in 2021, then tumbled by 89.24% to 0.0 in 2022, then tumbled by 88.79% to 0.0 in 2023.
  • Business Quant data shows Debt Ratio for PTGX at 0.0 in Q2 2023, 0.0 in Q1 2023, and 0.0 in Q4 2022.